We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
76
Adobe
ADBE
$98.5B
$14.4M 0.27%
25,046
+1,556
+7% +$979K
BA icon
77
Boeing
BA
$175B
$14.2M 0.27%
64,476
-5,759
-8% -$1.28M
EPD icon
78
Enterprise Products Partners
EPD
$82.5B
$14.1M 0.26%
651,203
+26,530
+4% +$603K
ZTS icon
79
Zoetis
ZTS
$31.9B
$13.9M 0.26%
71,711
-18,143
-20% -$3.66M
AXP icon
80
American Express
AXP
$228B
$13.8M 0.26%
82,612
-347
-0.4% -$58K
ENB icon
81
Enbridge
ENB
$121B
$13.7M 0.26%
344,938
-4,637
-1% -$183K
JNK icon
82
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
$13.6M 0.26%
124,609
+13,197
+12% +$1.45M
MRVL icon
83
Marvell Technology
MRVL
$165B
$13.4M 0.25%
222,266
-5,789
-3% -$347K
GM icon
84
General Motors
GM
$80B
$13.2M 0.25%
251,213
+25,856
+11% +$1.37M
LLY icon
85
Eli Lilly
LLY
$1.03T
$13.2M 0.25%
57,193
-4,785
-8% -$1.18M
GSY icon
86
Invesco Ultra Short Duration ETF
GSY
$3.86B
$12.8M 0.24%
254,006
+183,987
+263% +$9.29M
XBI icon
87
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$12.8M 0.24%
101,760
+10,591
+12% +$1.36M
XYL icon
88
Xylem
XYL
$27.3B
$12.7M 0.24%
102,698
-34,510
-25% -$4.44M
LMT icon
89
Lockheed Martin
LMT
$132B
$12.6M 0.24%
36,653
-1,066
-3% -$386K
SPHB icon
90
Invesco S&P 500 High Beta ETF
SPHB
$970M
$12.6M 0.23%
171,693
-158,862
-48% -$11.7M
MO icon
91
Altria Group
MO
$113B
$12.5M 0.23%
275,345
-11,001
-4% -$531K
MINT icon
92
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$12.4M 0.23%
121,379
+69,280
+133% +$7.06M
TGT icon
93
Target
TGT
$65.6B
$12.1M 0.23%
52,826
+159
+0.3% +$39.8K
SOXX icon
94
iShares Semiconductor ETF
SOXX
$41.7B
$11.9M 0.22%
79,956
-2,082
-3% -$316K
EHC icon
95
Encompass Health
EHC
$11B
$11.7M 0.22%
195,848
+31
+0% +$1.95K
STIP icon
96
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$11.6M 0.22%
109,977
+14,908
+16% +$1.58M
BX icon
97
Blackstone
BX
$102B
$11.6M 0.22%
99,575
-7,500
-7% -$870K
AFL icon
98
Aflac
AFL
$64.8B
$11.5M 0.22%
220,629
-240
-0.1% -$13.1K
VUG icon
99
Vanguard Morningstar Growth ETF
VUG
$218B
$11.5M 0.21%
237,186
-1,920
-0.8% -$95.5K
TWLO icon
100
Twilio
TWLO
$29B
$11.2M 0.21%
35,225
-3,607
-9% -$1.31M

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.